This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishigaki, K.
Right arrow Articles by Ruscetti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishigaki, K.
Right arrow Articles by Ruscetti, S.

 Previous Article  |  Next Article 

Journal of Virology, September 2001, p. 7893-7903, Vol. 75, No. 17
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.17.7893-7903.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

The Envelope Glycoprotein of Friend Spleen Focus-Forming Virus Covalently Interacts with and Constitutively Activates a Truncated Form of the Receptor Tyrosine Kinase Stk

Kazuo Nishigaki, Delores Thompson, Charlotte Hanson, Takashi Yugawa, and Sandra Ruscetti*

Basic Research Laboratory, National Cancer Institute, Frederick, Maryland

Received 14 February 2001/Accepted 30 May 2001

The Friend spleen focus-forming virus (SFFV) encodes a unique envelope glycoprotein, gp55, which allows erythroid cells to proliferate and differentiate in the absence of erythropoietin (Epo). SFFV gp55 has been shown to interact with the Epo receptor complex, causing constitutive activation of various signal-transducing molecules. When injected into adult mice, SFFV induces a rapid erythroleukemia, with susceptibility being determined by the host gene Fv-2, which was recently shown to be identical to the gene encoding the receptor tyrosine kinase Stk/Ron. Susceptible, but not resistant, mice encode not only full-length Stk but also a truncated form of the kinase, sf-Stk, which may mediate the biological effects of SFFV infection. To determine whether expression of SFFV gp55 leads to the activation of sf-Stk, we expressed sf-Stk, with or without SFFV gp55, in hematopoietic cells expressing the Epo receptor. Our data indicate that sf-Stk interacts with SFFV gp55 as well as gp55P, the biologically active form of the viral glycoprotein, forming disulfide-linked complexes. This covalent interaction, as well as noncovalent interactions with SFFV gp55, results in constitutive tyrosine phosphorylation of sf-Stk and its association with multiple tyrosine-phosphorylated signal-transducing molecules. In contrast, neither Epo stimulation in the absence of SFFV gp55 expression nor expression of a mutant of SFFV that cannot interact with sf-Stk was able to induce tyrosine phosphorylation of sf-Stk or its association with any signal-transducing molecules. Covalent interaction of sf-Stk with SFFV gp55 and constitutive tyrosine phosphorylation of sf-Stk can also be detected in an erythroleukemia cell line derived from an SFFV-infected mouse. Our results suggest that SFFV gp55 may mediate its biological effects in vivo by interacting with and activating a truncated form of the receptor tyrosine kinase Stk.


* Corresponding author. Mailing address: Basic Research Laboratory, Building 469, Room 205, National Cancer Institute---Frederick, Frederick, MD 21702-1201. Phone: (301) 846-5740. Fax: (301) 846-6164. E-mail: ruscetti{at}ncifcrf.gov.


Journal of Virology, September 2001, p. 7893-7903, Vol. 75, No. 17
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.17.7893-7903.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • He, S., Ni, S., Hegde, S., Wang, X., Sharda, D. R., August, A., Paulson, R. F., Hankey, P. A. (2010). Activation of the N-Terminally Truncated Form of the Stk Receptor Tyrosine Kinase Sf-Stk by Friend Virus-Encoded gp55 Is Mediated by Cysteine Residues in the Ecotropic Domain of gp55 and the Extracellular Domain of Sf-Stk. J. Virol. 84: 2223-2235 [Abstract] [Full Text]  
  • Subramanian, A., Hegde, S., Porayette, P., Yon, M., Hankey, P., Paulson, R. F. (2008). Friend Virus Utilizes the BMP4-Dependent Stress Erythropoiesis Pathway To Induce Erythroleukemia. J. Virol. 82: 382-393 [Abstract] [Full Text]  
  • Jelacic, T. M., Thompson, D., Hanson, C., Cmarik, J. L., Nishigaki, K., Ruscetti, S. (2008). The Tyrosine Kinase sf-Stk and Its Downstream Signals Are Required for Maintenance of Friend Spleen Focus-Forming Virus-Induced Fibroblast Transformation. J. Virol. 82: 419-427 [Abstract] [Full Text]  
  • Papetti, M., Skoultchi, A. I. (2007). Reprogramming Leukemia Cells to Terminal Differentiation and Growth Arrest by RNA Interference of PU.1. Mol Cancer Res 5: 1053-1062 [Abstract] [Full Text]  
  • Ni, S., Zhao, C., Feng, G.-S., Paulson, R. F., Correll, P. H. (2007). A Novel Stat3 Binding Motif in Gab2 Mediates Transformation of Primary Hematopoietic Cells by the Stk/Ron Receptor Tyrosine Kinase in Response to Friend Virus Infection. Mol. Cell. Biol. 27: 3708-3715 [Abstract] [Full Text]  
  • Nishigaki, K., Hanson, C., Ohashi, T., Spadaccini, A., Ruscetti, S. (2006). Erythroblast Transformation by the Friend Spleen Focus-Forming Virus Is Associated with a Block in Erythropoietin-Induced STAT1 Phosphorylation and DNA Binding and Correlates with High Expression of the Hematopoietic Phosphatase SHP-1. J. Virol. 80: 5678-5685 [Abstract] [Full Text]  
  • Gerlach, N., Schimmer, S., Weiss, S., Kalinke, U., Dittmer, U. (2006). Effects of Type I Interferons on Friend Retrovirus Infection. J. Virol. 80: 3438-3444 [Abstract] [Full Text]  
  • Brown, L., Benchimol, S. (2006). The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation: CELL CYCLE ARREST OR APOPTOSIS. J. Biol. Chem. 281: 3832-3840 [Abstract] [Full Text]  
  • Van Etten, R. A. (2006). The erythropoietin receptor lends a Friendly hand. Blood 107: 5-6 [Full Text]  
  • Zhang, J., Randall, M. S., Loyd, M. R., Li, W., Schweers, R. L., Persons, D. A., Rehg, J. E., Noguchi, C. T., Ihle, J. N., Ney, P. A. (2006). Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia. Blood 107: 73-78 [Abstract] [Full Text]  
  • Xie, L., Green, P. L. (2005). Envelope Is a Major Viral Determinant of the Distinct In Vitro Cellular Transformation Tropism of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2. J. Virol. 79: 14536-14545 [Abstract] [Full Text]  
  • Subramanian, A., Teal, H. E., Correll, P. H., Paulson, R. F. (2005). Resistance to Friend Virus-Induced Erythroleukemia in W/Wv Mice Is Caused by a Spleen-Specific Defect Which Results in a Severe Reduction in Target Cells and a Lack of Sf-Stk Expression. J. Virol. 79: 14586-14594 [Abstract] [Full Text]  
  • Nishigaki, K., Hanson, C., Jelacic, T., Thompson, D., Ruscetti, S. (2005). Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk. Proc. Natl. Acad. Sci. USA 102: 15488-15493 [Abstract] [Full Text]  
  • Wei, X., Ni, S., Correll, P. H. (2005). Uncoupling Ligand-dependent and -independent Mechanisms for Mitogen-activated Protein Kinase Activation by the Murine Ron Receptor Tyrosine Kinase. J. Biol. Chem. 280: 35098-35107 [Abstract] [Full Text]  
  • Nishigaki, K., Hanson, C., Thompson, D., Yugawa, T., Ruscetti, S. (2005). Activation of the Jun N-Terminal Kinase Pathway by Friend Spleen Focus-Forming Virus and Its Role in the Growth and Survival of Friend Virus-Induced Erythroleukemia Cells. J. Virol. 79: 12752-12762 [Abstract] [Full Text]  
  • Bardella, C., Costa, B., Maggiora, P., Patane', S., Olivero, M., Ranzani, G. N., De Bortoli, M., Comoglio, P. M., Di Renzo, M. F. (2004). Truncated RON Tyrosine Kinase Drives Tumor Cell Progression and Abrogates Cell-Cell Adhesion Through E-Cadherin Transcriptional Repression. Cancer Res. 64: 5154-5161 [Abstract] [Full Text]  
  • van den Akker, E., van Dijk, T., Parren-van Amelsvoort, M., Grossmann, K. S., Schaeper, U., Toney-Earley, K., Waltz, S. E., Lowenberg, B., von Lindern, M. (2004). Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors. Blood 103: 4457-4465 [Abstract] [Full Text]  
  • Rulli, K., Yugawa, T., Hanson, C., Thompson, D., Ruscetti, S., Nishigaki, K. (2004). Ex Vivo and In Vivo Biological Effects of a Truncated Form of the Receptor Tyrosine Kinase Stk When Activated by Interaction with the Friend Spleen Focus-Forming Virus Envelope Glycoprotein or by Point Mutation. J. Virol. 78: 4573-4581 [Abstract] [Full Text]  
  • Constantinescu, S. N., Keren, T., Russ, W. P., Ubarretxena-Belandia, I., Malka, Y., Kubatzky, K. F., Engelman, D. M., Lodish, H. F., Henis, Y. I. (2003). The Erythropoietin Receptor Transmembrane Domain Mediates Complex Formation with Viral Anemic and Polycythemic gp55 Proteins. J. Biol. Chem. 278: 43755-43763 [Abstract] [Full Text]  
  • Danilkovitch-Miagkova, A., Duh, F.-M., Kuzmin, I., Angeloni, D., Liu, S.-L., Miller, A. D., Lerman, M. I. (2003). Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc. Natl. Acad. Sci. USA 100: 4580-4585 [Abstract] [Full Text]  
  • Nishigaki, K., Thompson, D., Yugawa, T., Rulli, K., Hanson, C., Cmarik, J., Gutkind, J. S., Teramoto, H., Ruscetti, S. (2003). Identification and Characterization of a Novel Ste20/Germinal Center Kinase-related Kinase, Polyploidy-associated Protein Kinase. J. Biol. Chem. 278: 13520-13530 [Abstract] [Full Text]  
  • Lin, Y., Brown, L., Hedley, D. W., Barber, D. L., Benchimol, S. (2002). The death-promoting activity of p53 can be inhibited by distinct signaling pathways. Blood 100: 3990-4000 [Abstract] [Full Text]  
  • Dirks, C., Duh, F.-M., Rai, S. K., Lerman, M. I., Miller, A. D. (2002). Mechanism of Cell Entry and Transformation by Enzootic Nasal Tumor Virus. J. Virol. 76: 2141-2149 [Abstract] [Full Text]